Tempus AI, trading under the symbol NASDAQ:TEM, is preparing to release its quarterly earnings on Friday, August 8, 2025. Wall Street analysts predict an earnings per share (EPS) of -$0.23, with projected revenue of approximately $297.8 million. Founded in August 2015, Tempus AI focuses on using artificial intelligence to enhance patient care. The company went public in June 2024, marking its first year as a publicly traded entity.
Despite the initial excitement surrounding AI stocks, Tempus AI faced a challenging start in the stock market. The shares debuted at $40 on June 14, 2024, but experienced a sharp decline of 29% within the first week. However, as the market became more familiar with the company's focus on AI-driven patient care, the stock's performance improved significantly.
Tempus AI's financial metrics reveal some challenges. The company has a price-to-earnings (P/E) ratio of approximately -14.16, indicating negative earnings. The price-to-sales ratio is about 12.32, suggesting that investors are willing to pay $12.32 for every dollar of sales. The enterprise value to sales ratio is around 13.20, reflecting the company's valuation in relation to its sales.
The enterprise value to operating cash flow ratio is approximately -54.85, indicating negative operating cash flow. The earnings yield is -7.06%, further highlighting the company's negative earnings situation. Additionally, the debt-to-equity ratio is 2.63, suggesting a relatively high level of debt compared to its equity. However, the current ratio of 1.71 indicates that Tempus AI has a reasonable level of liquidity to cover its short-term liabilities.
